Ike Davis has already been ruled out for the rest of the season, but he is still awaiting word about whether the bone bruise in his left ankle will require surgery.
According to Steve Popper of the Bergen Record, Davis said before last night’s game that a decision will likely be made by Labor Day in order to ensure that he will have enough time to get ready for the start of next season. While microfracture surgery remains a possibility, Davis is hoping he will need a less serious procedure.
“I’ve just been in limbo for so long, I’m just looking forward to an answer. But they don’t have an answer until they go in there and then they find out what’s really going on in the joint.
“I’d rather not have surgery. I would like to avoid it, but if I can’t get better without it, I have to have surgery. To tell you the truth, I wish — obviously that I didn’t have to — but also, just waiting to have surgery and rehabbing to have surgery, it would be nice to just get it done if I have to have it done. The waiting game is kind of getting old.”
Davis appeared primed for a breakthrough season prior to colliding with teammate David Wright on May 10, batting .302/.383/.543 with seven home runs, 25 RBI and a .925 OPS over his first 149 plate appearances. While surgery will hopefully get his career back on track, the 24-year-old first baseman has been told by doctors that his ankle is “probably never going to feel the same.”
Rangers reliever Jake Diekman will have surgery on January 25 to help alleviate ulcerative colitis, an inflammatory bowel disease. As a result, the lefty will miss at least half of the 2017 regular season, Jeff Wilson of the Fort Worth Star-Telegram reports. Diekman was diagnosed with the illness when he was 11 years old. He has brought awareness to the Crohn’s and Colitis Foundation of America with a “Gut It Out” campaign.
Diekman, who turns 30 years old on Saturday, finished the 2016 campaign with a 3.40 ERA and a 59/26 K/BB ratio in 53 innings. He came to the Rangers from the Phillies in the Cole Hamels trade on July 31, 2015.
The Rangers and Diekman avoided arbitration last Friday, agreeing to a $2.55 million salary for the 2017 season.
It’s been on the verge of happening for a few days now, but now it’s official: the Toronto Blue Jays and Jose Bautista have reached a one-year deal with a mutual option. The deal is pending physical. An announcement making the deal official is expected later in week.
The exact financial figures have not been disclosed, but Jon Heyman reports that it will be in excess of the $17.2 million Bautista turned down when he turned down the Jays’ qualifying offer.
Bautista had a tough 2016, hitting .234/.366/.452 with 22 home runs and 69 RBI, and some clubs likely considered a long-term deal for the 36-year-old too risky, this leading to the relative lack of reported interest in Bautista by other clubs. But back-to-back ALCS appearances by the Jays and the success and popularity Bautista has experienced in Toronto make his re-signing there a pretty sensible move for all involved.